Treace Medical Concepts, Inc. (TMCI): R&D Expense

Annual figures by period end, from SEC filings.

$20.28M
Year ended 2025-12-31
$18.22M
Trailing 12 months to 2026-06-30
+14.3%
3-year compound annual growth
+28.2%
5-year compound annual growth
$20.59M2019-12-31: $5.07M2020-12-31: $5.85M2021-12-31: $10.20M2022-12-31: $13.58M2023-12-31: $15.44M2024-12-31: $20.59M2025-12-31: $20.28M$20.28M
2019-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$20.28M-1.5%2026-02-27, From 2025-01-01
2024-12-31$20.59M+33.3%2026-02-27, From 2024-01-01
2023-12-31$15.44M+13.7%2026-02-27, From 2023-01-01
2022-12-31$13.58M+33.1%2025-02-27, From 2022-01-01
2021-12-31$10.20M+74.5%2024-02-27, From 2021-01-01
2020-12-31$5.85M+15.3%2023-03-08, From 2020-01-01
2019-12-31$5.07Mn/a2022-03-04, From 2019-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Treace Medical Concepts, Inc. (TMCI)2025-12-31$20.28M-1.5%
SI-BONE, Inc. (SIBN)2025-12-31$17.45M+5.4%
Cerus Corp (CERS)2025-12-31$67.72M+15.0%
Orthopediatrics Corp (KIDS)2025-12-31$9.10M-17.5%
Lemaitre Vascular Inc (LMAT)2025-12-31$14.14M-9.7%
Heartflow, Inc. (HTFL)2025-12-31$64.92M+49.2%
SkinHealth Systems Inc. (SKIN)2025-12-31$5.63M-10.6%
Neuronetics, Inc. (STIM)2025-12-31$6.58M-48.4%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$71.28M+14.4%

Compare TMCI, SIBN, CERS, KIDS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗